atenolol has been researched along with Ventricular Fibrillation in 33 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 9.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "Metoprolol and other beta-adrenergic blocking drugs are known to exert cardioprotective effects that include significant reduction in occurrence of ventricular fibrillation (VF) following myocardial ischemia and infarction." | 7.67 | Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol. ( Beil, ME; Cabot, CF; Coram, WM; Olson, RW; Weiss, GB, 1987) |
| "Ventricular fibrillation was induced in 20 Landrace/Large White piglets, which were left untreated for 8 minutes before attempted resuscitation with precordial compression, mechanical ventilation, and electrical defibrillation." | 5.35 | Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. ( Bassiakou, E; Goulas, S; Koudouna, E; Papadimitriou, D; Papadimitriou, L; Prapa, V; Rokas, G; Xanthos, T, 2008) |
| "Ischemia-induced arrhythmias were studied during a 30 min period of occlusion of the left anterior descending (LAD) coronary artery, and 100% of control animals (n = 24) exhibited ventricular tachycardia and 63% ventricular fibrillation." | 5.27 | Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS, 1988) |
| "The greater sensitivity of phase 1a arrhythmias to beta-blockade and the lack of a decrease in ventricular fibrillation threshold during phase 1b might indicate differences in the genesis of arrhythmias and fibrillation in phases 1a and 1b." | 5.26 | Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. ( Bucher, P; Meesmann, W; Menken, U; Wiegand, V, 1979) |
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 5.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "In a large randomised trial of early beta-blockade in acute myocardial infarction (ISIS-1), almost all the reduction in mortality associated with the use of atenolol occurred on the day of admission or on the subsequent day." | 5.06 | Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. ( , 1988) |
| " During ischemia alone, the incidence of ventricular fibrillation in animals who underwent all phases of the study was 6 of 9; with atenolol (0." | 3.69 | Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar. ( Fusilli, L; Lee, W; Patel, J; Regan, TJ, 1994) |
| "Metoprolol and other beta-adrenergic blocking drugs are known to exert cardioprotective effects that include significant reduction in occurrence of ventricular fibrillation (VF) following myocardial ischemia and infarction." | 3.67 | Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol. ( Beil, ME; Cabot, CF; Coram, WM; Olson, RW; Weiss, GB, 1987) |
| "We analyzed the incidence and recurrence rate of early and late primary VF in 9,720 patients with a first acute MI, treated with thrombolytics, enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 trial." | 2.69 | Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. ( Cavalli, A; Negri, E; Santoro, L; Volpi, A, 1998) |
| "Diazepam treatment significantly reduced cumulative seizure behaviors by 79% compared to saline-treated animals but offered no cardiac protection." | 1.48 | Improved cardiac outcomes with combined atenolol and diazepam intervention in seizure. ( Harrison, JC; Kerr, DS; McCann, DM; Millen, RN; Read, MI; Sammut, IA, 2018) |
| "In 5 of 6 SHAM-treated animals, ventricular fibrillation (VF) occurred during LAD occlusion." | 1.39 | Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. ( Böhm, M; Linz, B; Linz, D; Mahfoud, F; Neuberger, HR; Pöss, J; Ukena, C; Wirth, K, 2013) |
| "Two patients with hypertrophic cardiomyopathy are reported from the recent experience of the Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, demonstrating limitations in the risk stratification algorithm currently used for this disease." | 1.35 | Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. ( Appelbaum, E; Haas, TS; Harrigan, CJ; Hauser, RG; Lesser, JR; Main, ML; Maron, BJ; Maron, MS; Roberts, WC, 2008) |
| " The doses for each drug were selected based on the results of dose-response curves." | 1.27 | Adrenergic effects on internal cardiac defibrillation threshold. ( Jones, DL; Klein, GJ; Rattes, MF; Sharma, AD; Szabo, T, 1987) |
| "Ischemia-induced arrhythmias were studied during a 30 min period of occlusion of the left anterior descending (LAD) coronary artery, and 100% of control animals (n = 24) exhibited ventricular tachycardia and 63% ventricular fibrillation." | 1.27 | Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS, 1988) |
| "The greater sensitivity of phase 1a arrhythmias to beta-blockade and the lack of a decrease in ventricular fibrillation threshold during phase 1b might indicate differences in the genesis of arrhythmias and fibrillation in phases 1a and 1b." | 1.26 | Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. ( Bucher, P; Meesmann, W; Menken, U; Wiegand, V, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (54.55) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Read, MI | 1 |
| Millen, RN | 1 |
| McCann, DM | 1 |
| Harrison, JC | 1 |
| Kerr, DS | 1 |
| Sammut, IA | 1 |
| Linz, D | 1 |
| Wirth, K | 1 |
| Ukena, C | 1 |
| Mahfoud, F | 1 |
| Pöss, J | 1 |
| Linz, B | 1 |
| Böhm, M | 1 |
| Neuberger, HR | 1 |
| Bassiakou, E | 1 |
| Xanthos, T | 1 |
| Koudouna, E | 1 |
| Goulas, S | 1 |
| Prapa, V | 1 |
| Papadimitriou, D | 1 |
| Rokas, G | 1 |
| Papadimitriou, L | 1 |
| He, G | 1 |
| Hu, J | 1 |
| Li, T | 1 |
| Ma, X | 1 |
| Meng, J | 1 |
| Jia, M | 1 |
| Lu, J | 1 |
| Ohtsu, H | 1 |
| Chen, Z | 1 |
| Luo, X | 1 |
| Imajo, N | 1 |
| Matsui, S | 1 |
| Yasui, Y | 1 |
| Matsui, N | 1 |
| Fukuishi, N | 1 |
| Akagi, M | 1 |
| Blagova, OV | 1 |
| Nedostup, AV | 1 |
| Ablad, B | 1 |
| Bjurö, T | 1 |
| Björkman, JA | 1 |
| Edström, T | 1 |
| Murphy, I | 1 |
| Moneley, D | 1 |
| Kelly, D | 1 |
| Foley, B | 1 |
| Sheehan, S | 1 |
| Maron, BJ | 1 |
| Maron, MS | 1 |
| Lesser, JR | 1 |
| Hauser, RG | 1 |
| Haas, TS | 1 |
| Harrigan, CJ | 1 |
| Appelbaum, E | 1 |
| Main, ML | 1 |
| Roberts, WC | 1 |
| Laakso, M | 1 |
| Pentikäinen, PJ | 1 |
| Pyörälä, K | 1 |
| Neuvonen, PJ | 1 |
| Thandroyen, FT | 1 |
| Worthington, MG | 1 |
| Higginson, LM | 1 |
| Opie, LH | 3 |
| Patterson, E | 1 |
| Lucchesi, BR | 1 |
| Lubbe, WF | 2 |
| Muller, CA | 1 |
| Worthington, M | 1 |
| McFadyen, EL | 1 |
| Djonlagić, H | 1 |
| Bos, I | 1 |
| Diederich, KW | 1 |
| Lu, HR | 1 |
| Remeysen, P | 1 |
| De Clerck, F | 1 |
| Patel, J | 1 |
| Lee, W | 1 |
| Fusilli, L | 1 |
| Regan, TJ | 1 |
| Adamson, PB | 1 |
| Huang, MH | 1 |
| Vanoli, E | 1 |
| Foreman, RD | 1 |
| Schwartz, PJ | 1 |
| Hull, SS | 1 |
| Raza, A | 1 |
| Volpi, A | 1 |
| Cavalli, A | 1 |
| Santoro, L | 1 |
| Negri, E | 1 |
| Clements-Jewery, H | 1 |
| Curtis, MJ | 1 |
| Podzuweit, T | 1 |
| Daries, PS | 1 |
| Wiegand, V | 2 |
| Güggi, M | 1 |
| Meesmann, W | 3 |
| Kessler, M | 1 |
| Greitschus, F | 1 |
| Menken, U | 1 |
| Bucher, P | 1 |
| Abendroth, RR | 1 |
| Stephan, K | 1 |
| Schley, G | 1 |
| Hübner, H | 1 |
| Coram, WM | 1 |
| Olson, RW | 1 |
| Beil, ME | 1 |
| Cabot, CF | 1 |
| Weiss, GB | 1 |
| Ren, XL | 1 |
| Lin, CX | 1 |
| Rattes, MF | 1 |
| Sharma, AD | 1 |
| Klein, GJ | 1 |
| Szabo, T | 1 |
| Jones, DL | 1 |
| Odugbesan, O | 1 |
| Chesner, IM | 1 |
| Bailey, G | 1 |
| Barnett, AH | 1 |
| Kinoshita, K | 1 |
| Hearse, DJ | 1 |
| Braimbridge, MV | 1 |
| Manning, AS | 1 |
6 trials available for atenolol and Ventricular Fibrillation
| Article | Year |
|---|---|
Prevention of ventricular fibrillation requires central beta-adrenoceptor blockade in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Baroreflex; Blood Pressure; Central Nervous System; | 2007 |
Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atenolol; Drug Administration Routes; Electrocardio | 1998 |
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind | 1979 |
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Topics: Administration, Oral; Age Factors; Aged; Atenolol; Cardiotonic Agents; Clinical Trials as Topic; Dru | 1986 |
Intravenous beta-blockade during acute myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Humans; Injec | 1986 |
Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.
Topics: Atenolol; Clinical Trials as Topic; Coronary Disease; Heart Rupture; Humans; Ireland; Myocardial Inf | 1988 |
27 other studies available for atenolol and Ventricular Fibrillation
| Article | Year |
|---|---|
Improved cardiac outcomes with combined atenolol and diazepam intervention in seizure.
Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Atenolol; Diazepam; Drug Therapy, Combination; Ele | 2018 |
Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Disease Models, Animal; Kidney; Male; Myocardial Reperfus | 2013 |
Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cardiopulmonary Resuscitation; Drug Therapy, Combina | 2008 |
Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Famotidine; Heart; Heart Rate; Hist | 2012 |
The protective effect of H2-receptor activation against the duration of myocardial hypoxia/reoxygenation-induced ventricular fibrillation in sensitized guinea-pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cytoplasmic Granules; Dimaprit; Electrocardiography; | 2005 |
[Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Atrioventricular Node; Calcium Channel Blockers; | 2006 |
Endoscopic thoracic sympathectomy for long QT syndrome.
Topics: Adrenergic beta-Antagonists; Atenolol; Defibrillators, Implantable; Electric Countershock; Female; H | 2008 |
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiomyopathy, Hypertrophic; Defibrillato | 2008 |
Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Heart Ventricles; Humans; Kinetics; Male | 1981 |
The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Ate | 1983 |
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relation | 1984 |
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.
Topics: Adenosine Triphosphate; Animals; Atenolol; Coronary Disease; Cyclic AMP; Heart; Male; Myocardium; Ph | 1981 |
[Sympathetic ganglionitis in the hereditary syndrome of QT prolongation (Romano-Ward syndrome); intracardiac registration of after-potentials (author's transl)].
Topics: Adult; Arrhythmias, Cardiac; Atenolol; Autonomic Nervous System Diseases; Autopsy; Electrocardiograp | 1982 |
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disea | 1995 |
Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Disease Models, Animal; Dogs; Heart | 1994 |
Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death.
Topics: Animals; Atenolol; Autonomic Nervous System; Death, Sudden, Cardiac; Dogs; Heart; Heart Rate; Longit | 1994 |
Beta-receptor blockade in preventing sudden death.
Topics: Adrenergic beta-Antagonists; Atenolol; Death, Sudden, Cardiac; Humans; Metoprolol; Practolol; Sotalo | 1993 |
Modulation of ventricular arrhythmias by catecholamines during evolving infarction in the isolated perfused rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Catecholamines; Coronary Circulation; Electrocardiog | 2001 |
The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.
Topics: Adenosine Triphosphate; Animals; Atenolol; Bucladesine; Cyclic AMP; Epinephrine; Myocardium; Phospho | 1978 |
Extracellular potassium activity changes in the canine myocardium after acute coronary occlusion and the influence of beta-blockade.
Topics: Animals; Atenolol; Coronary Disease; Dogs; Extracellular Space; Female; Heart; Male; Myocardium; Pot | 1979 |
Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Dogs; Drug Administration Schedule; Heart Rate; Isoproteren | 1979 |
[Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)].
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Carotid Arteries; Coronary Disease; Coronary Vessels; Dogs; | 1977 |
Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Topics: Animals; Atenolol; Differential Threshold; Dogs; Drug Combinations; Isoproterenol; Lidocaine; Metopr | 1987 |
[The electrophysiologic effect of atenolol and nitrendipine on normal and ischemic rabbit myocardium in situ. III. Effects on ventricular fibrillation threshold].
Topics: Animals; Atenolol; Electric Stimulation; Electrophysiology; Female; Male; Myocardial Infarction; Nit | 1989 |
Adrenergic effects on internal cardiac defibrillation threshold.
Topics: Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Electric Countershock; Isoprote | 1987 |
Hazards of combined beta-blocker/diuretic tablets.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Combinations; Female; Humans; Hypokalemia; M | 1985 |
Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Male; Myocard | 1988 |